Involvement of Transforming Growth Factor β and its Type 1 Receptor in the Development of Breast Cancer
✍ Scribed by V. V. Keshelava; O. S. Khodorovich; G. O. Shaykhaev; N. L. Chazova; A. M. Bereschanskaya
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 672 KB
- Volume
- 152
- Category
- Article
- ISSN
- 0007-4888
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The progression of breast cancer depends on the establishment of a neovasculature, by a process called angiogenesis. Angiogenesis is an invasive cellular event that requires the co-ordination of numerous molecules including growth factors and their receptors, extracellular proteins, adhesion molecul
Forty-three sporadic gastric cancers were analyzed with regard to whether mutations of simple repeated sequences in the transforming growth factor fi type II receptor ( T p -I / ) gene are associated with microsatellite instability (MSI) and gastric carcinogenesis. In 12 ofthe 43 cancers (28%), MSI
Alteration of transforming growth factor beta1 (TGF-beta1) type II receptor (RII) appears to cause unresponsiveness to TGF-beta1 in tumorigenic cells. Defect in the mononucleotide repeat sequence, i.e., poly A region of TGF-beta1RII gene has been reported to be related to replication error-positive
At least one member of the TGF-P family, TGF-p1, has been previously shown to inhibit the anchorage-independent growth of some human breast cancer cell lines (Knabbe et al., 1487; Arteaga et al., 1988). Members of the TGF-P family might, [herefore, provide new strategies for breast cancer therapy. W